Latest News
EQT to acquire biosurgery company Corza Biosurgery
7 July 2026 - Swedish private equity company EQT AB (STO: EQT) said on Tuesday it has agreed to acquire the specialist biologics business Corza Biosurgery from global medical technology company Corza Medical, via its EQT X fund.Corza Biosurgery devel...
Ascletis submits two IND applications to US FDA for obesity treatments
7 July 2026 - Integrated biotechnology company Ascletis Pharma Inc (HKEX: 1672) has announced the submission of two Investigational New Drug (IND) applications to the US Food and Drug Administration (FDA) for ASC36, a once-monthly to once-quarterly n...
AbbVie's TEPKINLY (epcoritamab) combination approved in Europe to treat relapsed or refractory follicular lymphoma
7 July 2026 - US pharmaceutical company AbbVie (NYSE:ABBV) announced on Monday that the European Commission has granted marketing authorisation for TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the treatmen...
AMO Pharma updates on scientific advice for AMO-02 registrational clinical study in congenital myotonic dystrophy type 1
7 July 2026 - AMO Pharma Limited, a UK-based clinical-stage specialty biopharmaceutical company, on Monday announced agreement with regulatory agencies in the US, UK and Canada on design for a registrational clinical study intended to assess the safe...
IceCure reports growing adoption of ProSense cryoablation in Brazil
6 July 2026 - Cryoablation technology company IceCure Medical (NASDAQ: ICCM) reported on Monday that commercial adoption and physician interest in its ProSense cryoablation system are increasing in Brazil following its recent US FDA clearance for the...